Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.94 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Share-based Compensation (2025 - 2026)

Updated

Polaryx Therapeutics (PLYX) recorded Share-based Compensation of $467,000 in Q1 2026, down 89.5% from $4.45 million a year earlier.

Analysis

Polaryx Therapeutics (PLYX) Share-based Compensation (2025 - 2026) Analysis & Trends

For FY2025, Polaryx Therapeutics reported Share-based Compensation of $4.73 million, up 96.9% from FY2024.

  • Across earlier years, Share-based Compensation came in at $2.4 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 357.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 166.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 231.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 249.00 Mn
10 Polaryx Therapeutics 93.18 Mn 68.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 467,000.00
Jun 30, 2025 109,000.00
Mar 31, 2025 4.45 Mn
API Access

Polaryx Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PLYX&period=max&api_key=YOUR_API_KEY